ClinicalTrials.gg
CompletedNCT07841652Updated Nov 12, 2026

Scapular Stabilization Versus Proprioceptive Neuromuscular Facilitation Technique in Scapular Dyskinesis

An interventional study of Scapular Stabilization Exercises+ Proprioceptive Neuromuscular Facilitation and Patient engagement through warm-up and Scapular Stabilization exercises in Scapular Dyskinesis, sponsored by University of Lahore. Completed at 1 site in Pakistan. Open to participants aged 20 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by University of Lahore · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Nov 2025, registered Jun 2026).
Updated Nov 12, 2026Now CompletedNow Active, not recruiting+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
20 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 18 studies in Pain by University of Lahore — 2 open to participants now, 2 under way, none of them phase 3. Pain · University of Lahore.

Enrollment
3rd of 18
86 · median 72
Started
2025
with 3 others
No phase
18 of 18
2 open now
Registered
18th of 18
by date

Among the 18 studies in Pain by University of Lahore, this one is the 3rd largest by enrollment, is one of 4 that started in 2025, is one of 18 with no phase, and was the 18th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

2 of the 18 studies in Pain by University of Lahore are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 20 Years to 55 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Pain by University of Lahore, or all of them as a file.
02

Study summary

Office workers, typically engaged in administrative or professional roles, are increasingly susceptible to scapular dyskinesis (SD). Poor ergonomic setups at workstations have been identified as a major contributing factor to musculoskeletal discomfort in this population. Scapular stabilization and neuromuscular training have shown efficacy in improving scapular mechanics. However, direct comparisons of these interventions in office worker populations remain limited. To address this knowledge gap, a randomized clinical trial was conducted to directly compare the two treatment approaches. Outcome measures included the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, Numeric Pain Rating Scale (NPRS), digital inclinometer, and digital vernier caliper to determine which method is more effective in reducing pain, disability, and improving shoulder ROM, and scapular kinematics in office workers with Scapular Dyskinesis.

Read the detailed description

Scapular dyskinesis is a common musculoskeletal disorder characterized by abnormal movement or positioning of the scapula (shoulder blade). This condition is commonly associated with prolonged sedentary work, poor ergonomic practices, and sustained postures. Office workers who use computers for prolonged periods are increasingly experiencing neck and shoulder pain. Poor ergonomic setups at workstations have been identified as a major contributing factor to musculoskeletal discomfort in this population. Studies have shown that using a keyboard for 4 to 6 hours per day significantly increases the risk of developing neck and shoulder pain compared with less frequent computer use. Furthermore, many office workers adopt a forward head posture for extended periods, which places stress on the soft tissues of the cervical spine. Prolonged stress can negatively affect shoulder and scapular function, often resulting in alterations in normal scapular movement. Scapular stabilization exercises are designed to improve scapular position and control, while proprioceptive neuromuscular facilitation (PNF) training focuses on coordinated scapular movements and muscle activation. The purpose of this randomized controlled trial is to compare the effectiveness of scapular stabilization exercises with proprioceptive neuromuscular activation training in office workers with scapular dyskinesis. The primary outcomes of the study include pain and functional disability. Secondary outcomes include shoulder range of motion (ROM) and scapular kinematics . The findings of this study may provide evidence regarding the effectiveness of scapular stabilization and proprioceptive neuromuscular activation training for improving pain, shoulder range of motion, functional ability and scapular kinematics in office workers with scapular dyskinesis.

03

Conditions studied

  • Scapular Dyskinesis

Browse trials for

Keywords

  • Scapular dyskinesis
  • Office workers
  • Scapular stabilization exercises
  • proprioceptive neuromuscular facilitation
  • pain
  • disability
  • range of motion
04

Who can participate

The criteria were revised on the registry on Nov 12, 2026. See what changed

Ages eligible
20 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Both male and females

      • White-collar jobbers working ≥4 h/day, 40 h/week; >1 year experience.
      • Pain 4-7/10 (NPRS)
      • Visual Scapular Dykinesis test and Lateral Scapular Slide Test LSST, confirmed by a physical therapist.

Exclusion criteria

Exclusion Criteria:

    • Orthopedic upper-extremity injury in last 3 weeks; prior shoulder/upper-limb surgery.

      • Neurological disorders of neck/upper limb; current participation in upper-limb rehab.
      • Postural deformities (e.g., scoliosis, cervical pathology); pregnancy; conditions preventing scapular testing; history of major trauma (e.g., RTA, spinal disc pathology).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
86 participants (actual)

Study arms

  • Experimental
    Scapular Stabilization + Proprioceptive Neuromuscular Facilitation Group

    Participants in this arm received scapular stabilization exercises combined with proprioceptive neuromuscular facilitation (PNF) and moist heat. Each 55-minute session consisted of 10 minutes of moist heat, 25 minutes of scapular stabilization exercises, and 20 minutes of PNF training. Treatment will be administered three sessions per week for six weeks, for a total of 18 sessions.

    Other: Scapular Stabilization Exercises+ Proprioceptive Neuromuscular Facilitation

  • Active comparator
    Scapular Stabilization Group

    Participants in this arm received scapular stabilization exercises combined with warm-up and mobility exercises and moist heat. Each 55-minute session consisted of 10 minutes of moist heat, 20 minutes of warm-up and mobility exercises, and 25 minutes of scapular stabilization exercises. Treatment will be administered three sessions per week for six weeks, for a total of 18 sessions.

    Other: Patient engagement through warm-up and Scapular Stabilization exercises

Interventions

  • OtherScapular Stabilization Exercises+ Proprioceptive Neuromuscular Facilitation

    The group received standard conventional treatment consisting of a moist heating pad applied for 10 minutes, followed by 25 minutes of scapular stabilization exercises and 20 minutes of proprioceptive neuromuscular facilitation. Treatment was administered three times per week for six weeks. The scapular stabilization component included prone Y, T, and W raises performed in a prone position, with the arms elevated approximately 10-15 cm while maintaining scapular retraction and depression. Participants performed 3 sets of 10-12 repetitions with a 2-second pause. Scapular push-ups were performed from a prone plank position with active scapular protraction for 3 sets of 8-10 repetitions. Wall-slide elevation with mirror feedback was performed for 3 sets of 12-15 repetitions while maintaining scapular control. Resistance-band rows were performed for 12-15 repetitions. Scapular D1 and D2 PNF patterns were performed with light manual resistance, 3 sets of 8-10 reps with 5-second holds.

  • OtherPatient engagement through warm-up and Scapular Stabilization exercises

    Patients performed low-intensity engagement exercises to improve adherence, relaxation, and patient comfort during rehabilitation sessions. These activities included wall climbing (finger ladder/wall stair exercises), pendulum exercises, shoulder rolls, active shoulder range-of-motion exercises, pectoralis stretching, and thoracic mobility exercises performed within a pain-free range. Application of moist heating pad for 10 minutes. , 20 minutes of patient engagement+25 min scapular stabilization. 3 sessions per week for 6 weeks. The scapular stabilization exercises included Prone Y/T/W raises performed in prone position, with the arms raised 10-15 cm to create T, Y (thumbs up), and W positions while maintaining scapular retraction and depression. Participants performed 3 sets of 10-12 repetitions, with a 2-second pause. Scapular push-ups were performed from a prone plank position with engaged scapular protraction for 3 sets of 8-10 reps. Wall-slide elevation with mirror feedback.

06

What researchers measure

Primary outcomes

  1. Pain intensity

    Pain intensity (Numeric Pain Rating Scale, NPRS; 0-10), 0 indicates no pain and 10 indicates the worst pain.

    Time frame: At baseline, at 3rd week and at 6th week.

  2. Upper extremity functional disability

    (Disabilities of the Arm, Shoulder and Hand questionnaire - DASH), Scores range from 0 to 100, where 0 indicates no disability (better function) and 100 indicates the greatest disability (worse function).

    Time frame: at baseline, at 3rd week and at 6th week.

Secondary outcomes

  1. Shoulder range of motion (ROM)

    digital inclinometer measuring flexion, abduction, internal rotation, and external rotation

    Time frame: at baseline, at 3rd week and at 6th week

  2. Scapular index

    digital vernier calliper measuring scapular index

    Time frame: at baseline ,at 3rd week and at 6th week.

  3. scapular upward rotation

    scapular upward rotation at 0°,45°and 90° measured by using digital inclinometer

    Time frame: at baseline ,at 3rd week and at 6th week.

  4. Lateral Scapular Slide Test

    measures scapular symmetry

    Time frame: at baseline ,at 3rd week and at 6th week.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

3 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2025 to primary completion in Aug 2026, 9 months.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 9 months is close to that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

Primary completion moved twice since we started tracking on Sep 25, 2026: Sep 2026 → Aug 2026, last on Nov 12, 2026.

Completion moved twice since we started tracking on Sep 25, 2026: Oct 2026 → Sep 2026, last on Nov 12, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 28, 2026
First posted
Sep 25, 2026
StartActual
Nov 15, 2025
Primary completionActual
Aug 20, 2026was Sep 2026
CompletionActual
Sep 20, 2026was Oct 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Active, not recruiting→Completed
changed Oct 19, 2026 · changed Nov 12, 2026
Primary completion
Sep 20, 2026→Aug 20, 2026 (actual)
moved 2 times, Oct 19, 2026 – Nov 12, 2026
Study completion
Oct 20, 2026→Sep 20, 2026 (actual)
moved 2 times, Oct 19, 2026 – Nov 12, 2026
Eligibility
1 inclusion criterion edited
What changed in the criteria
Inclusion criteria
  • EditedPositiveVisual Scapular Assistance Test (SAT)Dykinesis test and Lateral Scapular Slide Test LSST, confirmed by a physical therapist.
Nov 12, 2026
Secondary outcomes
1 edited, 2 added, 2 removed
What changed in the outcomes
  • EditedScapular kinematicsindexTime frame: at baseline ,at 3rd week and at 6th week.
  • Addedscapular upward rotationTime frame: at baseline ,at 3rd week and at 6th week.
  • AddedLateral Scapular Slide TestTime frame: at baseline ,at 3rd week and at 6th week.
  • RemovedNeuromuscular controlTime frame: at baseline, at 3rd week and at 6th week.
  • RemovedNeuromuscular ControlTime frame: at baseline, 3rd week and at 6th week.
Nov 12, 2026
Registered
First appeared on the registry
Sep 25, 2026
Show all 3 updates
  1. Nov 12, 2026
    Active, not recruiting→Completed
    Primary completion Oct 15, 2026→Aug 20, 2026 (now actual)
    Study completion Nov 20, 2026→Sep 20, 2026 (now actual)
    Eligibility 1 inclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • EditedPositiveVisual Scapular Assistance Test (SAT)Dykinesis test and Lateral Scapular Slide Test LSST, confirmed by a physical therapist.
    Secondary outcomes 1 edited, 2 added, 2 removed
    What changed in the outcomes
    • EditedScapular kinematicsindexTime frame: at baseline ,at 3rd week and at 6th week.
    • Addedscapular upward rotationTime frame: at baseline ,at 3rd week and at 6th week.
    • AddedLateral Scapular Slide TestTime frame: at baseline ,at 3rd week and at 6th week.
    • RemovedNeuromuscular controlTime frame: at baseline, at 3rd week and at 6th week.
    • RemovedNeuromuscular ControlTime frame: at baseline, 3rd week and at 6th week.
    + 3 other changes: verification date, description and conditions
  2. Oct 19, 2026
    Enrolling by invitation→Active, not recruiting
    Primary completion Sep 20, 2026→Oct 15, 2026
    Study completion Oct 20, 2026→Nov 20, 2026
    + 1 other change: verification date
  3. Sep 25, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07841652
Responsible party
Sponsor
First posted
Sep 25, 2026
Start date
Nov 15, 2025
Primary completion
Aug 20, 2026
Completion
Sep 20, 2026
Last update
Nov 12, 2026

Study contacts

Sahreen Anwar, Ph.D
study chair · University of Lahore

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion